In addition to the Research Award and Research Grant opportunities offered by IFFGD, a few other organizations also offer research funding opportunities:

 

DoD Gulf War Illness Biorepository Resource Network Award

Deadline: September 28, 2017

Description: The Biorepository Resource Network Award (BRNA) is intended to provide infrastructure support for the development of a Gulf War Illness (GWI) biorepository comprised of a network of institutions that will collect, process, annotate, store, and distribute high-quality biospecimens and data from Veterans of 1990-1991 Persian Gulf War. The development of a biorepository resource network will enable the GWI research community to conduct research that will address the mission of the Gulf War Illness Research Program.

Amount: Estimated total program funding of $4,000,000

For information and application: www.grants.gov

DoD Gulf War Illness Clinical Consortium Award

Deadline: September 28, 2017

Description: The Gulf War Illness Research Program (GWIRP) Clinical Consortium Award mechanism is intended to support a major goal-/product-driven Consortium of exceptional institutions and investigators that will accelerate the clinical translation of basic GWI research into clinical therapies and ultimately decrease the impact of the illness.

Amount: Estimated total program funding of $8,000,000

For information and application: www.grants.gov

DoD Gulf War Illness Investigator-Initiated Focused Research Award

Deadline: September 28, 2017

Description: This funding opportunity supports research to promote new ideas or continued development of applied research in Gulf War Illness (GWI) that is aimed at diagnosis or therapeutic advancement. Applications must articulate the pathway to making a clinical impact for Veterans with GWI even if a clinical impact is not an immediate outcome.

Amount: Estimated total program funding of $4,100,000

For information and application: www.grants.gov

DoD Gulf War Illness Qualitative Research Award

Deadline: September 28, 2017

Description: Qualitative research is a form of social inquiry that seeks to understand the human experience by exploring how people interpret and make sense of their experiences and the world in which they live. The intent of this funding opportunity is to support qualitative research studies that seek to understand the experiences, perceptions, barriers, and beliefs of Veterans suffering from GWI and those responsible for their care. 

Amount: Estimated total program funding of $1,300,000

For information and application: www.grants.gov

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplements and Natural Products

Deadline: October 15, 2017

Description: This funding opportunity will build on existing NIH awards to support the performance and publication of formal single-laboratory validation studies of relevant quantitative analytical methods relating to the study of dietary supplements and natural products.

Amount: Application budgets are limited to no more than 25% of the Council-approved direct costs for the current budget year of the project or $100,000 (direct costs), whichever is less, and must reflect the actual needs of the proposed validation studies.

For information and application: www.grants.gov

DoD Peer Reviewed Medical Research Program Technology/Therapeutic Development Award

Deadline: October 18, 2017

Description: The PRMRP Technology/Therapeutic Development Award is a product-driven award mechanism intended to provide support for the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, in at least one of the Congressionally directed FY17 PRMRP Topic Areas. Products in development should be responsive to the healthcare needs of military Service members, Veterans, and/or beneficiaries.  

Amount: The anticipated direct costs budgeted for an entire period of performance for an FY17 PRMRP Technology/Therapeutic Development Award will not exceed $3M.

For information and application: www.grants.gov

DoD Peer Reviewed Medical Research Program Investigator-Initiated Research Award

Deadline: October 18, 2017

Description: The PRMRP Investigator-Initiated Research Award is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to at least one of the Congressionally directed FY17 PRMRP Topic Areas. The rationale for a research idea may be derived from a laboratory discovery, population-based studies, a clinician's first-hand knowledge of patients, or anecdotal data. 

Amount: The anticipated direct costs budgeted for an entire period of performance for a single PI FY17 PRMRP IIRA award will not exceed $1.2M.

For information and application: www.grants.gov

DoD Peer Reviewed Medical Research Program Focused Program Award

Deadline: October 26, 2017

Description: The PRMRP Focused Program Award mechanism is intented to optimize research and accelerate the solution for a critical question related to at least one of the Congressionally directed FY17 PRMRP Topic Areas through a synergistic, multidisciplinary research program. 

Amount: The anticipated total costs budgeted for the entire period of performance for an FY17 PRMRP Focused Program Award will not exceed $10M. 

For information and application: www.grants.gov

American Neurogastroenterology & Motility Society (ANMS) Small Grants Program

Deadline: November 3, 2017

Description: The 2018 ANMS Research Program will provide up to 2 grants of $30,000 each. The program will fund research projects focused on any topic area relevant to neurogastroenterology and motility. It is anticipated that one award will be made to a clinical/translational investigator and one award will be made to a basic science investigator. Applicants and their mentors must be current members of the ANMS.

Amount: Two grants of $30,000 each will be awarded.

For information and application: www.motilitysociety.org/grant_application.php

Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21)

Deadline: May 8, 2018

Description: This funding opportunity announcement encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic disorders, including thyroid, parathyroid, and Cushing's diseases and acromegaly; and genetic metabolic diseases including cystic fibrosis, lyosomal storage diseases, and disorders of the urea cycle, amino acid metabolism, and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases.   

Amount: Direct costs are limited to $275,000 over an R21 two-year period, with no more than $200,000 in direct costs allowed in any single year.  

For information and application: www.grants.nih.gov

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01)

Deadline: May 8, 2018

Description: The purpose of this funding opportunity announcement is twofold: (1) to stimulate basic and mechanistic science that facilitates the development of effective probiotics or pre-/probiotics in appropriate test systems and animal models.

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For information and application: www.grants.nih.gov

Pilot Feasability Clinical and Translational Research Studies in Digestive Diseases and Nutrition (R21)

Deadline: September 8, 2018

Description: The goal of this pilot and feasability mechanism is to provide flexibility for initiating preliminary, short-term clinical or translational studies, thus allowing new ideas to be investigated in a more expeditious manner without stringent requirements for preliminary data. Applications submitted should propose research studies that will facilitate the translation of promising and relevant new developments into the clinical setting or that will advance our understanding of pathophysiological mechanisms that may become the basis for diagnostic or therapeutic development. 

Amount: Direct costs are limited to $250,000 over an R21 two-year period. 

For information and application: www.grants.nih.gov/grants/

High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2) 

Deadline: November 2, 2018

Description: The purpose of this high impact, interdisciplinary science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of the NIDDK. The interdisciplinary approach encouraged by this FOA is envisioned to generate a community research resource for the broader community, which may include discovery-based or hypothesis-generating science.  

Amount: The total annual cost of individual awards is expected to vary, depending on the scope of the project and the number of participating institutions. Application budgets are not limited but are expected to reflect the actual needs of the proposed project.  

For information and application: www.grants.gov/grants/

Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21)

Deadline: January 7, 2019

Description: The purpose of this funding opportunity announcement is to provide support for new investigators from backgrounds nationally underrepresented in biomedical and behavioral research to conduct small research projects in the scientific mission areas of the NIDDK.

Amount: Up to $125,000

For information and application: www.grants.gov/grants/

NIDDK Program Projects (P01)

Deadline: May 8, 2019

Description: This funding opportunity announcement invites submission of investigator-initiated program project applications. The proposed programs should address scientific areas relevant to the NIDDK mission, including diabetes, selected endocrine and metabolic diseases, obesity, digestive diseases and nutrition, and kidney, urologic, and hematologic diseases, as well as new approaches to prevent, treat, and cure these diseases, including clinical research.

Amount: Applications should not request more than $6.25 million in direct costs over 5 years. 

For information and application: www.grants.gov/grants/

Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01)

Deadline: May 8, 2019

Description: The overarching goal of this funding opportunity announcement is to translate basic science research into knowledge and tools that can be utilized to provide strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the NIDDK. 

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For information and application: www.grants.gov/grants/

Mechanisms, Models, Measurement, and Management in Pain Research (R01)

Deadline: May 8, 2019

Description: The purpose of this funding opportunity announcement is to inform the scientific community of the pain research interests of the various institutes and centers at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the mission of these centers. 

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For information and application: www.grants.gov/grants/

NIDDK Exploratory Clinical Trials for Small Business (R44)

Deadline: September 6, 2019

Description: The purpose of this funding opportunity announcement is to provide a vehicle for Small Business Concerns (SBCs) submitting Small Business Innovation Research (SBIR) grant applications for investigator-initiated exploratory clinical trials to the NIDDK. The projects must focus on products related to the mission and goals of the NIDDK and may evaluate drugs, biologics, or devices, as well as surgical, behavioral, or rehabilitation therapies. 

Amount: Total funding support (direct costs, indirect costs, fees) may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards.

For information and application: www.grants.gov/grants/

Assay Development and Screening to Discover Therapeutic or Imaging Agents for Diseases of Interest to the NIDDK (R01)

Deadline: September 8, 2019

Description: The goal of this funding opportunity announcement is to develop, validate, or conduct a screen using a novel assay to identify therapeutic or imaging agents relevant to health related outcomes of interest to the NIDDK. It is expected that state of the art measures of basic cellular processes or molecular events that are key mediators of disease pathogenesis are incorporated into these novel assays.

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project.

For information and application: www.grants.gov/grants/

Lead Optimization and Preclinical Development of Therapeutic Candidates for Diseases of Interest to the NIDDK (R41/R42)

Deadline: January 6, 2020

Description: The goal of this funding opportunity announcement is to support lead optimization and preclinical development of new therapies for diseases within the mission of the NIDDK with the STTR program.

Amount: While total funding support normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II, with appropriate justification from the applicant, applications may exceed these caps by up to 50%.  

For information and application: www.grants.gov/grants/

Ancillary Studies to the NIDDK Intestinal Stem Cell Consortium (R01)

Deadline: January 8, 2020

Description: This funding opportunity announcement invites research projects to improve understanding of the causes of high priority diseases in the United States and reducing/eliminating health disparities. 

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. 

For information and application: www.grants.gov/grants/

Addressing Health Disparities in NIDDK Diseases (R01)

Deadline: January 8, 2020

Description: This funding opportunity announcement invites research projects to improve understanding of the causes of high priority diseases in the United States and reducing/eliminating health disparities. 

Amount: Application budgets are not limited but need to reflect the actual needs of the proposed project. 

For information and application: www.grants.gov/grants/

Biomarkers for Diabetes, Digestive, Kidney and Urologic Diseases Using Biosamples from the NIDDK Repository (R01)

Deadline: May 8, 2020

Description: This funding opportunity will provide support for assays (and associated data analysis) of repository-held samples for studies focused on NIDDK relevant diseases.

Amount: Application budgets are limited to $250,000 direct costs per year and must reflect the actual needs of the proposed project.

For information and application: www.grants.gov/grants/

Do you have a research grant opportunity of interest to the digestive health community? Contact us if you would like IFFGD to post it.

Research Awards
2013 Award Recipients
Enrico Corazziari, MD
Jan Tack, MD, PhD
Gary Mawe, PhD
Ashley Blackshaw, PhD
Carlo Di Lorenzo, MD
Niranga Manjuri Devanarayana, MD
Report from Lukas Van Oudenhove, PhD: Solving the Biopsychosocial Puzzle in Functional Dyspepsia
Muriel Larauche, PhD
2011 Award Recipients
Report from Ronnie Fass, MD: Sleep and Gastroesophageal Reflux Disease (GERD)
Million Mulugeta, PhD
Adrian Miranda, MD
Samuel Nurko, MD
Sudarshan Jadcherla, MD
Shaman Rajindrajith, MD
2009 Award Recipients
Satish Rao, MD
Emeran Mayer, MD
Javier Santos, MD
Report from Martin Storr, MD, PhD: Functional Gastrointestinal Disorders: New Insights in Enteric Regulation
Report From Miguel Saps, MD: Functional Abdominal Pain in Children and Adolescents
2007 Award Recipients
Report from Bruce D. Naliboff, PhD: Symptom Based Psychology for Functional Gastrointestinal Disorders
Report from Magnus Simrén, MD, PhD: Irritable Bowel Syndrome: Searching for Underlying Causes
Report from Brennan M. R. Spiegel, MD, MSHS: Diagnostic Testing in Irritable Bowel Syndrome: Theory vs. Reality
Report from Sylvie Bradesi, PhD: Role of the Central Immune System in Functional Disorders
Paul E. Hyman, MD
Report from Miranda A. L. van Tilburg, PhD: Home Based Guided Imagery to Treat Pediatric Functional Abdominal Pain
Report from Fernando Azpiroz, MD, PhD: Understanding Intestinal Gas
2005 Award Recipients
Report from Yvette Tache, PhD: Stress and Irritable Bowel Syndrome: Unraveling the Code
Report from Shaheen Hamdy, MRCP, PhD: Adult Neurogenic Dysphagia -- Disorders and Conditions that Disrupt Swallowing
Report from Michael A. Pezzone, MD, PhD: Chronic Pelvic Pain and the Overlap of Pelvic Pain Disorders
Report from Bridget R. Southwell, PhD: Research into Treatment-Resistant Constipation in Children
Report from Rachel Rosen, MD, MPH: Symptoms Arising from Non-Acid Reflux in Children
2003 Award Recipients
Report from William E. Whitehead, PhD: Summary of Clinical Research Activities
Jyoti N. Sengupta, PhD
Report from Caroline Elder Danda, PhD: Biopsychosocial Perspectives on Assessment and Treatment
Report from Terry Buchmiller-Crair, MD: Using the Fetal Gastrointestinal Tract to Overcome Neonatal Disease
Report from Dan L. Dumitrascu, MD, PhD: The Psychosocial Adjustment to Illness in Irritable Bowel Syndrome
Report from Klaus Bielefeldt, MD, PhD: Understanding Pain and Discomfort in Functional GI Disorders
Research Grants
IFFGD Competitive Grants
2014 IFFGD Idiopathic Gastroparesis Research Grants
Leo Cheng, PhD
Braden Kuo, MD, MSc
Richard McCallum, MD
2008 IFFGD Competitive Research Grants
IFFGD Noncompetitive Grants
Other Research Grant Opportunities
Funding Research
Need for Funding Research
How to Make a Difference
The State of Research at NIH & NIDDK
Clinical Trials & Studies
IBS Studies
Guide to Randomized Clinical Trials
Industry Sponsored Clinical Trials and Studies
NIH/Other Sponsored Clinical Trials and Studies